Health & Biotech
Check out the latest Biotech news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Escrow Watch
ASX Escrow Watch: Lithium companies dominate in releasing shares
Health & Biotech
Check Up: Imugene’s oncolytic virus VAXINIA granted FDA’s Fast Track, but how effective is this novel therapy?
Health & Biotech
ASX Health Stocks: 4DX shares continue ascent after signing a deal with global player, Philips
Health & Biotech
ASX Health Stocks: Nova Eye catches a break as US Medicare reimbursement decision deferred until March
Health & Biotech
“Market is going to be surprised” as Firebrick Pharma set to launch antiviral nasal spray, Nasodine
Health & Biotech
ASX Health Stocks: EMvision calls its AI brain scanner ’emu’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat as a pancake but hopes still of Christmas rally
Health & Biotech
ASX Health Stocks: Rhythm Bio says new research in lung cancer is warranted after this finding
Health & Biotech
ASX Health Stocks: Chimeric jumps 35pc as cell therapy drug shows pre-clinical efficacy
Health & Biotech
‘Strongly positioned to move the business forward’: Race Oncology appoints new CEO
Health & Biotech
REPORT: ASX wound care is rapidly becoming an ‘exciting subsector’
Health & Biotech
ASX Health Stocks: Painchek’s Europe patent accepted; and HeraMed signs deal with Telstra Health
Health & Biotech
ASX Health Stocks: 4DX jumps 15pc after FDA clearance; while AI-focused biotechs TrivarX and Artrya also gain
Health & Biotech
ScoPo’s Powerplays: Could ASX health stocks up for third week be a start of a Christmas rally?
Health & Biotech
ASX Health Stocks: Singular jumps 18pc after securing funds, Tax Office wipes smile off Pacific
Health & Biotech
Why these ASX firms are shying away from the pot stock label – Part Two
Experts
Dr Boreham’s Crucible: Nanosonics is testing more patience than ever. Is it a case of ‘relax and it won’t hurt a bit’?
Health & Biotech
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
News
In Case You Missed It: Firebrick back after review points to ‘inaccuracies in trial efficacy data’
Health & Biotech
ASX Health Stocks: EBR stumbles 11pc after warning of FDA delay; Firebrick’s trial data shows ‘inaccuracies’
Health & Biotech
Why these ASX firms are shying away from the ‘pot stock’ label – Part One
Health & Biotech
ASX Health Stocks: Forget surgery, Orthocell says tennis elbow can be fixed with its tendon cell therapy
News
10 at 11ish: Keypath Education eyes profitability in FY24, Metal Bank’s high-grade copper find at Malaqa
Health & Biotech
ASX Health Stocks: 4DX skyrockets 54pc after US update on its XV LVAS scanning device
News
10 at 11ish: 4D Medical gets US tick, First Lithium bounces on Blakala update
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Yoga = chill. Fact. And ASX health stocks up for second week
News
ASX Small Caps and IPO Weekly Wrap: Up days, down days = flat week; Medtech multiplies its mojo
Health & Biotech
ASX Health Stocks: AVITA flies as high as 24pc after providing a big, bullish guidance
News
10 at 11ish: Who’s up on news about lithium projects at Lake Johnston today?
News
In Case You Missed It: Krakatoa soars on thick King Tamba pegmatites in big day for resources stocks
Health & Biotech
ASX Health Stocks: Race Oncology gets certified for RC220; human trials next
Health & Biotech
Weed Week: Jamaican nettletree could be a new, cheaper option to source CBD, says scientists
News
Closing Bell: ASX up for another day, Optus plugs back in as Telstra gains
Health & Biotech
ASX Health Stocks: HeraMED jumps 30pc after maternity care platform goes live at clinical trial
News
10 at 11ish: Identified pegmatites spur Golden State Mining to kick off drilling at Paynes Find
News
In Case You Missed It: New gold licence for Mantle, Stelar Metals to start lithium drill program
Health & Biotech
ASX Health Stocks: Clarity Pharma, Island Pharma set to embark on next steps of clinical trials
Health & Biotech
ASX Health Stocks: PYC on the same page with FDA, Cleo’s cancer test peer-reviewed
Experts
CRITERION: Paradigm’s set for a proper knees-up if its arthritis fighter is the real deal
Health & Biotech
ScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)
Health & Biotech
ASX Health Stocks: Neuren up 17pc on DAYBUE sales, Argenica +40pc on Alzheimer’s data
News
10 at 11ish: MC Mining bounces on takeover bid, Block rockets
Health & Biotech
ASX Health Stocks: Island Pharma granted Aussie patent for flavivirus infection drug, ISLA-101
Health & Biotech
ASX Biotech October Winners: Dimerix, Noxopharm and Chimeric dominate as investors hunt next big thing in pharma
Health & Biotech
ASX Health Stocks: IDT on strong growth trajectory, Paradigm smashed 30pc on cap raise
News
10 at 11ish: Magnum Mining inks Saudi deal, Novonix scores US$100m grant
Health & Biotech
Q+A: Mach 7 CEO Mike Lampron on a barnstorming year and why AI isn’t the easy win it looks like
Load More
